Systems and Methods for Ex Vivo Lung Care
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/024,976, filed Jan 31, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,317,888 | Systems and Methods for Ex Vivo Lung Care In force · High confidence | Transmedics, Inc. | In force | High confidence | ||
| US 10,750,738 | Systems and Methods for Ex Vivo Lung Care In force · High confidence | Transmedics, Inc. | In force | High confidence | ||
| US 9,814,230 | SYSTEMS AND METHODS FOR Ex vivo LUNG CARE In force · Medium confidence | Transmedics, Inc. | In force | Medium confidence | ||
| US 9,247,728 | Systems and Methods for Ex Vivo Lung Care In force · Medium confidence | Transmedics, Inc. | In force | Medium confidence | ||
| US 9,462,802 | Systems and Methods for Ex Vivo Lung Care In force · High confidence | Transmedics, Inc. | In force | High confidence | ||
| Application 19/203,814 | Systems and Methods for Ex Vivo Lung Care Pending Not granted | Transmedics, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Transmedics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.